中信证券股份有限公司 关于优利德科技（中国）股份有限公司股东 向特定机构投资者询价转让股份 相关资格的核查意见 广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座 中信证券股份有限公司（以下简称"中信证券"）受优利德科技（中国）股 份有限公司（以下简称"优利德"）股东拓利亚一期企业管理（东莞）中心（有 限合伙）、拓利亚二期企业管理（东莞）中心（有限合伙）、拓利亚三期企业管 理（东莞）中心（有限合伙）（以下简称"出让方"）委托，组织实施本次优利 德首发前股东向特定机构投资者询价转让（以下简称"本次询价转让"）。 根据《关于在上海证券交易所设立科创板并试点注册制的实施意见》《科创 板上市公司持续监管办法（试行）》《上海证券交易所科创板股票上市规则（2025 年 4 月修订）》《上海证券交易所科创板上市公司自律监管指引第 4 号——询价 转让和配售（2025 年 3 月修订）》（以下简称"《询价转让和配售指引》"）等 相关规定，中信证券对参与本次询价转让股东的相关资格进行核查，并出具本核 查意见。 一、本次询价转让的委托 中信证券收到出让方关于本次询价转让的委托，委托中信证券组织实施本次 询价转让。 二、关 ...

证券代码：688628 证券简称：优利德 公告编号：2025-019 优利德科技（中国）股份有限公司 股东询价转让计划书 拓利亚一期企业管理（东莞）中心（有限合伙）、拓利亚二期企业管理（东 莞）中心（有限合伙）、拓利亚三期企业管理（东莞）中心（有限合伙）（以下 合称"出让方"）保证向优利德科技（中国）股份有限公司（以下简称"优利德" 或"公司"）提供的信息内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其真实性、准确性和完整性依法承担法律责任。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 一、拟参与转让的股东情况 （一）出让方的名称、持股数量、持股比例 此外，公司实际控制人承诺通过出让方间接持有的股份不参与本次询价转让， 部分公司董事、高级管理人员在本次询价转让通过出让方转让间接持有的优利德 股份。 （三）出让方关于拟转让股份权属清晰、不存在限制或者禁止转让情形、不 违反相关规则及其作出的承诺的声明 出让方声明，出让方所持股份已经解除限售，权属清晰。出让方不存在《上 市公司股东减持股份管理暂行办法》《上海证券交易所上市公司自律监管指引第 15 号——股东及董事、高 ...

Investment Rating - The investment rating for the company is "Outperform the Market" [5][6]. Core Views - The company is experiencing steady revenue growth, with a projected 10.81% increase in revenue for 2024, reaching 1.13 billion yuan, and a 13.64% increase in net profit, amounting to 183 million yuan [2][5]. - The company's strategy focuses on the high-end and specialized instrument sectors, which is expected to drive further growth and improve product structure [5][6]. - Despite a strong performance in 2024, the first quarter of 2025 shows a slight profit pressure due to increased depreciation from the Vietnam factory and high R&D expenses [4][5]. Financial Performance Summary - For 2024, the company achieved a gross margin of 45.16% and a net margin of 15.85%, reflecting improvements of 1.84 and 0.33 percentage points year-on-year, respectively [3][4]. - The revenue breakdown by business segments for 2024 includes: - Testing Instruments: Revenue of 155 million yuan, up 14.62%, with a gross margin of 42.56% [3]. - General Instruments: Revenue of 660 million yuan, up 8.33%, with a gross margin of 46.02% [3]. - Specialized Instruments: Revenue of 92 million yuan, up 72.94%, with a gross margin of 50.82% [3]. - Temperature and Environmental Testing Instruments: Revenue of 219 million yuan, down 0.21%, with a gross margin of 42.34% [3]. - The company forecasts net profits of 228 million yuan, 274 million yuan, and 314 million yuan for 2025, 2026, and 2027, respectively, with corresponding P/E ratios of 17, 15, and 13 [5][6].

Investment Rating - The investment rating for the company is "Outperform the Market" [5][6][22]. Core Views - The company is experiencing steady revenue growth, with a projected 10.81% increase in revenue for 2024, reaching 1.13 billion yuan, and a 13.64% increase in net profit, amounting to 183 million yuan [2][5]. - The company's strategy focuses on the high-end and specialized instrument sectors, which is expected to drive further growth and improve product structure [5][6]. - The first quarter of 2025 shows a revenue increase of 9.58% year-on-year, but profit is under pressure due to increased depreciation from the Vietnam factory and high R&D expenses [4][5]. Financial Performance Summary - For 2024, the company achieved a gross margin of 45.16% and a net margin of 15.85%, reflecting improvements of 1.84 and 0.33 percentage points respectively [3][4]. - The revenue breakdown by business segment for 2024 includes: - Testing Instruments: Revenue of 155 million yuan, up 14.62%, with a gross margin of 42.56% [3]. - General Instruments: Revenue of 660 million yuan, up 8.33%, with a gross margin of 46.02% [3]. - Specialized Instruments: Revenue of 92 million yuan, up 72.94%, with a gross margin of 50.82% [3]. - Temperature and Environmental Testing Instruments: Revenue of 219 million yuan, down 0.21%, with a gross margin of 42.34% [3]. - The company maintains high R&D and sales expenses, with the expense ratios for 2024 being 10.40% for sales, 6.91% for management, and 10.36% for R&D [3][4]. Earnings Forecast - The earnings forecast for the company indicates a net profit of 228 million yuan in 2025, 274 million yuan in 2026, and 314 million yuan in 2027, with corresponding P/E ratios of 17, 15, and 13 [5][6][23].

北京德恒（东莞）律师事务所 关于优利德科技（中国）股份有限公司 2024 年年度股东大会的 法律意见 广东省东莞市南城总部基地蜂汇广场 1 栋 31、35 层 电话：0769-23229888 邮编：523000 北京德恒（东莞）律师事务所 关于优利德科技（中国）股份有限公司 2024 年年度股东大会的法律意见 北京德恒（东莞）律师事务所 关于优利德科技（中国）股份有限公司 2024 年年度股东大会的 法律意见 德恒 29G20250035-0001 号 致：优利德科技（中国）股份有限公司 北京德恒（东莞）律师事务所（以下简称"本所"）接受优利德科技（中国） 股份有限公司（以下简称"公司"）的委托，根据《中华人民共和国证券法》（以 下简称《证券法》）、《中华人民共和国公司法》（以下简称《公司法》）、中国证券 监督管理委员会《上市公司股东会规则》（以下简称《股东会规则》）等中华人民 共和国（以下简称"中国"，为本法律意见之目的，不包括中国香港特别行政区、 中国澳门特别行政区和中国台湾地区）法律、行政法规、部门规章、规范性文件 和现行有效的《优利德科技（中国）股份有限公司章程》（以下简称《公司章程》） 的规定，指 ...

本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 证券代码：688628 证券简称：优利德 公告编号：2025-018 优利德科技(中国)股份有限公司 2024年年度股东大会决议公告 （一） 股东大会召开的时间：2025 年 5 月 6 日 （二） 股东大会召开的地点：广东省东莞市松山湖园区工业北一路 6 号优利德 科技（中国）股份有限公司会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 59 | | --- | --- | | 普通股股东人数 | 59 | | 2、出席会议的股东所持有的表决权数量 | 70,392,275 | | 普通股股东所持有表决权数量 | 70,392,275 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 63.6820% | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 6 ...

公募基金方面，本期较上一期持股增加的公募基金共计6个，主要包括汇丰晋信价值先锋股票A、金鹰 元和混合A、交银启信混合发起A、大成可转债增强债券A、申万宏源双季增享6个月债券A等，持股增 加占比达0.21%。本期较上一季度持股减少的公募基金共计4个，包括交银先进制造混合A、华泰柏瑞富 利混合A、交银启明混合A、明亚中证1000指数增强A，持股减少占比达0.77%。本期较上一季未再披露 的公募基金共计115个，主要包括华泰柏瑞鼎利混合A、鹏华价值优势混合(LOF)、工银中小盘混合、融 通互联网传媒灵活配置混合、国泰君安君得明混合等。 2025年4月25日，优利德(688628.SH)发布2025年第一季报。截至2025年4月30日，共有18个机构投资者 披露持有优利德A股股份，合计持股量达7301.62万股，占优利德总股本的65.61%。其中，前十大机构 投资者包括优利德集团有限公司、中国农业银行股份有限公司-交银施罗德先进制造混合型证券投资基 金、拓利亚二期企业管理(东莞)中心(有限合伙)、招商银行股份有限公司-交银施罗德均衡成长一年持有 期混合型证券投资基金、中国工商银行股份有限公司-汇添富科创板2年定期开放 ...

Core Insights - The company reported a revenue of 1.13 billion yuan for 2024, representing a year-on-year growth of 10.81%, and a net profit attributable to shareholders of 183 million yuan, up 13.64% year-on-year [1] - For Q1 2025, the company achieved a revenue of 311 million yuan, a year-on-year increase of 9.58%, with a net profit of approximately 55.11 million yuan, reflecting a modest growth of 0.91% [1] Financial Performance - In 2024, the company's professional instruments segment generated revenue of 91.53 million yuan, a significant increase of 72.94% year-on-year, driven by product launches in power and renewable energy applications [2] - The gross profit margin for the main products improved by 1.88 percentage points to 45.22% in 2024, benefiting from optimized sales structure [3] - The sales net profit margin for 2024 was 15.85%, an increase of 0.33 percentage points, while the gross profit margin was 45.16%, up 1.84 percentage points [3] Strategic Initiatives - The company is focusing on high-end, specialized, and international strategies, which have led to sustained growth in its product lines [2] - The company has increased its R&D and market development investments by 18.51% and 10.35% respectively in Q1 2025, indicating a commitment to innovation [4] - The establishment of an overseas production base in Vietnam aims to enhance international competitiveness and mitigate risks associated with global market fluctuations [4] Market Outlook - The company anticipates that equipment upgrades and the demand for self-controlled solutions will act as catalysts for growth in the instrumentation industry [5] - The projected net profit for 2025-2027 is estimated at 210 million yuan, 240 million yuan, and 290 million yuan, with respective year-on-year growth rates of 12.4%, 17.6%, and 17.9% [5]

Summary of the Earnings Call for Youli Technology (2025 Q1) Company Overview - **Company**: Youli Technology - **Industry**: Instrumentation and Testing Equipment Key Financial Performance - **Revenue Growth**: Approximately 15% year-on-year in Q1 2025, with overall revenue growth of 9.58% [2][3] - **Gross Margin**: Slight decline of 2-3 percentage points due to high costs from the trial production at the Vietnam factory and inventory clearance of low-end brands. Excluding these factors, the main business gross margin improved year-on-year [2][3] - **Profit Growth**: Profit growth of nearly 1%, lower than revenue growth due to decreased gross margin and increased operating expenses [2][3] Expense Analysis - **R&D, Sales, and Management Expenses**: Combined expenses increased by 17% year-on-year, totaling over 74 million. R&D expenses rose by 18.5% due to an increase in personnel and project costs related to the Vietnam factory [5] - **Projected Annual Expense Growth**: Expected to grow by approximately 10% for the year [5] Revenue by Region and Product Line - **Domestic Revenue**: Increased by 12.25% year-on-year [6] - **Overseas Revenue**: Increased by 7.26% year-on-year, with overseas orders growing over 15% [6] - **Testing Instruments**: Notable performance with an 18.55% increase, particularly strong growth in overseas markets exceeding 40% [6] New Product Launches - **High-End New Products**: Launched new high-end products in April 2025, including power load safety compliance instruments, aimed at sectors like renewable energy and automotive electronics [7][8] International Expansion - **Overseas Sales Network**: Continued establishment of subsidiaries in the US and Germany, with plans for expansion in the Asia-Pacific region. The Vietnam factory has commenced production and is in a rapid ramp-up phase [9] Shareholder Returns - **Dividends**: Consistent increase in annual dividends since listing, with a total dividend of 1.3 yuan per share in 2024, representing a payout ratio of 78% [10] Market Environment and Strategy - **Tariff Impact**: The tariff policy has accelerated the domestic substitution process, with increased acceptance of domestic products among industrial clients [4][23] - **Growth Targets**: The company aims for annual revenue and profit growth of no less than 20%, particularly focusing on high-end instruments and specialized equipment [4][16] Production and Supply Chain - **Vietnam Factory**: Designed for a capacity of 300 million yuan, with low initial investment leading to a gross margin that is expected to be at least on par with domestic levels [17] - **Domestic Supply Chain Resilience**: High levels of domestic component sourcing, with 99% localization in instrumentation products, ensuring minimal impact from potential supply chain disruptions [19] Competitive Landscape - **Price Increases by Competitors**: Some US-based competitors have raised prices significantly, impacting market dynamics and accelerating the domestic substitution trend [15][25] Future Outlook - **Q2 Expectations**: Anticipated stable growth in orders and performance, particularly in domestic and Southeast Asian markets, with a goal of maintaining double-digit growth [12] - **Testing Instruments Growth Target**: Set at no less than 20% for the testing instruments segment [30] Conclusion - **Overall Sentiment**: The company remains optimistic about its growth trajectory despite external challenges, with a strong focus on high-end product development and international market expansion.

优利德科技（中国）股份有限公司 UNI-TREND TECHNOLOGY（CHINA）CO., LTD 2024 年年度股东大会 会议材料 会议时间：2025年5月6日 目录 | 2024 年年度股东大会会议须知 | | | 3 | | --- | --- | --- | --- | | 2024 | 年年度股东大会议程 | | 5 | | 议案一：关于《2024 | | 年年度报告》及摘要的议案 | 7 | | 议案二：关于《2024 | | 年度董事会工作报告》的议案 | 8 | | 议案三：关于《2024 | | 年度监事会工作报告》的议案 | 9 | | 议案四：关于《2024 | | 年度财务决算报告》的议案 | 10 | | 2024 | 议案五：关于 | 年度利润分配预案的议案 | 11 | | 议案六：关于续聘 | | 2025 年度审计机构的议案 | 12 | | 议案七：关于公司 | | 2025 年度董事、监事薪酬方案的议案 | 13 | | 附件 | 1：《2024 | 年董事会工作报告》 | 14 | | 附件 | 2：《2024 | 年度监事会工作报告》 | 19 | | 附件 3 ...